August 2020

Professor Valérie Vilgrain from Clichy, France, has presented the Plenary Lecture entitled 'Liver resilience' at ECR 2020.

Dr. Valérie Vilgrain is Chair of the Department of Radiology at the University Beaujon Hospital and Professor of Radiology at the University of Paris, France. Her major research interests are diagnostic and interventional imaging of the liver, pancreas and bile ducts with a special interest in multidetector CT and MR imaging and contrast-enhanced ultrasound, functional imaging (CT perfusion, dynamic contrast-enhanced MR imaging, diffusion-weighted MR imaging).

Dr. Vilgrain received her MD from the Rene Descartes University of Paris, Medical School, in 1985. She was resident in Radiology at Paris University and she completed a Fellowship in Radiology at the University Beaujon Hospital, Clichy, France (1987-1988).

Dr. Vilgrain is member of several international and national societies, such as ESR (European Society of Radiology), ESGAR (European Society of Gastro Abdominal Radiology), EASL (European Association for the Study of Liver), RSNA (Radiological Society of North America), and SFR (French Radiological Society). She was chairperson of the Education Program Committee of the SFR annual meeting from 2000-2008 and has been Vice-Chairman of the French Society from 2010 to 2014. She chaired the RSNA Regional Committee for Europe from 2015 to 2018. She is the Scientific/Educational Director of ESOR (European School of Radiology) since March 2018.

Valerie Vilgrain

Dr. Vilgrain has published 450 peer-reviewed papers (H-Number: 74, Scopus) and has been the principal investigator of several large multicenter clinical trials, including the SARAH study of SIRT vs sorafenib in primary liver cancer. Since 2012 she has participated to many European guidelines: liver transplantation for hepatocellular carcinoma, management of patients with neuroendocrine liver metastases, management of benign liver tumours, management of hepatocellular carcinoma, and consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.

She has served on the Editorial Board of Radiology (Associate Editor 2007-2012, Consultant to the Editor 2012-2017), and she is currently on the Editorial Board of Journal of Hepatology and Abdominal Radiology. She is a reviewer for several radiological journals: Radiology, European Radiology, AJR, European Journal of Radiology and clinical journals: Hepatology, Journal of Hepatology, Gut, Liver Transplantation, and European Journal of Cancer.